Notably, CDKN2A/B deletions can be identified in tumours with as few as 6 or more mitotic figures per 10 HPF, but tumours with high mitotic counts may not necessarily have CDKN2A/B deletion. The gene discussed is CDKN2A; the disease is neoplasm.